SIM2, associated with clinicopathologic features, promotes the malignant biological behaviors of endometrial carcinoma cells
Abstract Background Endometrial carcinoma (EC) poses a significant threat to women’s health. Identifying effective prognostic biomarkers and therapeutic targets is essential for improving survival rates in EC patients. This study aimed to identify key regulators involved in EC progression and invest...
Saved in:
| Main Authors: | Hua Nie, Yu Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14077-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clear cell endometrial carcinoma: analysis of the results of a 20-year follow-up
by: K. P. Laktionov, et al.
Published: (2014-08-01) -
Prognostic parameters in FIGO stage I endometrial carcinoma of endometrioid type
by: Stanojević Zorica, et al.
Published: (2006-01-01) -
DNA methylation-driven genes in hepatocellular carcinoma patients: insights into immune infiltration and prognostic implications
by: Zhi Zhang, et al.
Published: (2025-04-01) -
The Impact of High lncRNA Expression on Clinicopathological Characteristics and Prognosis of Endometrial Cancer Patients: A Meta‐Analysis
by: Xiaotong Zhao, et al.
Published: (2025-03-01) -
The impact of cyclin D1 on endometrial hyperplasia and endometrioid endometrial carcinoma
by: Sudha M, et al.
Published: (2025-06-01)